A 72-year-old woman with a medical history of pancreatic adenocarcinoma status after pancreatoduodenectomy and adjuvant therapy with chemoradiotherapy presented with fever and jaundice 17 months after undergoing pancreatoduodenectomy. She underwent CT scan of the abdomen without contrast medium, which showed dilatation of the afferent loop and dilatation of the intrahepatic and extrahepatic ducts suggestive of afferent limb syndrome. The radiologic findings were also highly suggestive of pancreatic cancer recurrence. ERCP could not be performed at an outside hospital because of a high-grade stricture at the afferent limb. Percutaneous biliary drainage was placed. Endoscopic evaluation revealed a nontraversable stricture, 10 cm long, at the afferent limb. A hydrophilic guidewire could not be advanced across the stricture. Therefore, EUS-guided drainage was attempted ([Fig. 1](#fig1){ref-type="fig"}; [Video 1](#appsec1){ref-type="sec"}, available online at [www.VideoGIE.org](http://www.videogie.org){#intref0010a}). A mixed solution of contrast medium with methylene blue was instilled through the biliary drainage catheter to distend the afferent limb. The distended limb was localized by EUS and was targeted with a 19-gauge FNA needle. A guidewire was then advanced to the afferent limb lumen, and a 15-mm × 10-mm lumen-apposing metallic stent (LAMS) and electrocautery enhanced delivery system was used to create a gastrojejunostomy. The patient progressed satisfactorily, with improvement of her symptoms. A follow-up study with contrast medium was performed 48 hours after the procedure, which demonstrated the LAMS was in place with adequate flow of contrast medium to the afferent and efferent limb. There was no evidence of leakage. In conclusion, endoscopically created gastroenteric anastomosis is a safe and effective procedure for relief of afferent limb syndrome.Figure 1Afferent limb syndrome. **A**, CT view showing dilatation of the intrahepatic and extrahepatic ducts (*white arrow*), dilatation of the afferent loop (*red arrow*), and ascites suggestive of afferent limb syndrome. **B**, Fluoroscopic view demonstrating a nontraversable stricture 10-cm long at the afferent limb (*red line*). **C**, EUS view also revealing a dilatated loop of small bowel (*red arrow*), consistent with afferent limb syndrome. **D**, Instillation of a mixed solution of saline solution, contrast medium, and methylene blue through a previously placed percutaneous transhepatic cholangiography tube to dilate the afferent limb; EUS view revealing a dilatated loop of small bowel. The dilated jejunal loop was targeted with a 19-gauge FNA needle and a blue solution was suctioned from the jejunal lumen (*red arrow*), confirming a good position of the FNA needle into the afferent limb lumen. **E**, Advancement of a LAMS to the afferent limb lumen over the guidewire and deployment of the distal flange (*red arrow*). **F**, Dilation of the gastrojejunostomy (*red arrow*). **G**, Final endoscopic view of the proximal end of the LAMS (gastric side). *LAMS*, lumen-apposing metallic stent.
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Video 1Percutaneously assisted EUS-guided gastrojejunostomy for the treatment of afferent limb syndrome.Video Script

Written transcript of the video audio is available online at [www.VideoGIE.org](http://www.VideoGIE.org){#intref0010}.
